Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prometrium for Menopausal Vasomotor Symptoms
NCT00152438Phase 2Unknown
- Sponsor
- University of British Columbia
- Start
- Sep 2005
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in vasomotor symptoms of menopause (VMS) comparing Prometrium with Placebo (2 arms). Primary endpoints: Vasomotor symptoms frequency and intensity at 4 months and Forearm blood flow by plethysmography at 3 months. Status: unknown.
02
Drugs
progesterone
03
Conditions
vasomotor symptoms of menopause (VMS)
Beyond the preview
Go deeper on NCT00152438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152438.